Science Explorer Back to mapMap
Discussion
Topic · Pulmonary and Respiratory Medicine

Pleural and Pulmonary Diseases

Pleural and Pulmonary Diseases is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 34k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis and management of various pleural diseases, including pleural effusion, empyema, pneumothorax, and tuberculous pleural effusion. It covers topics such as thoracoscopy, pleurodesis, malignant pleural effusion, parapneumonic effusions, pleural catheter insertion, and thoracentesis.

  • Pleural Effusion
  • Empyema
  • Pneumothorax
  • Thoracoscopy
  • Pleurodesis
  • Tuberculous Pleural Effusion
  • Malignant Pleural Effusion
  • Parapneumonic Effusions
  • Pleural Catheter
  • Thoracentesis
Research works
34k
fractional, since 1950
In the world top 10%
3.4k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+0%
the tick is no change
Largest producer
United States
30% of the 10 largest, 2022-now
Pleural and Pulmonary Diseases

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Pleural and Pulmonary Diseases research?

By volume, the United States and China publish the most (1.3k and 805 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.3k works
  2. 2 China 805 works
  3. 3 Japan 512 works
  4. 4 India 433 works
  5. 5 United Kingdom 318 works
  6. 6 Germany 265 works
  7. 7 Italy 230 works
  8. 8 Spain 189 works
  9. 9 Türkiye 189 works
  10. 10 France 127 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 30.1%China: 18.3%Japan: 11.7%India: 9.9%6 others listed: 30.0%30%largest
United States1,324 · 30.1%China805 · 18.3%Japan512 · 11.7%India433 · 9.9%6 others listed1,319 · 30.0%

Shares of the rows listed above, not of the whole node.

Which institutions lead Pleural and Pulmonary Diseases research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Pleural and Pulmonary Diseases research, followed by Harvard University and Sichuan University.

By volume, 2022-now

  1. 1 All India Institute of Medical SciencesIndia 48 works
  2. 2 Harvard UniversityUnited States 47 works
  3. 3 Sichuan UniversityChina 41 works
  4. 4 Mayo ClinicUnited States 32 works
  5. 5 Capital Medical UniversityChina 30 works
  6. 6 Shanghai Jiao Tong UniversityChina 23 works
  7. 7 Heidelberg UniversityGermany 22 works
  8. 8 University of OxfordUnited Kingdom 21 works
  9. 9 Tongji UniversityChina 20 works
  10. 10 Zhejiang UniversityChina 20 works

Who are the leading researchers in Pleural and Pulmonary Diseases?

The most-cited researchers publishing on Pleural and Pulmonary Diseases include Gordon Henry Guyatt, Gregory Y.H. Lip and Jean‐Louis Vincent.

  1. 1 Gordon Henry Guyatt Canada 315k citations
  2. 2 Gregory Y.H. Lip United Kingdom 311k citations
  3. 3 Jean‐Louis Vincent Belgium 262k citations
  4. 4 Carlo La Vecchia Italy 258k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Pleural and Pulmonary Diseases?

The most cited paper in Pleural and Pulmonary Diseases is "Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma" (Nicholas J. Vogelzang, James J. Rusthoven, James Thomas Symanowski et al., 2003), with 3,089 citations. Next come "A Randomized Trial Comparing Lung-Volume–Reduction Surgery with Medical Therapy for Severe Emphysema" (2,082) and "Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy" (1,814).

Most cited papers
#PaperReleasedCitations
1 Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma Nicholas J. Vogelzang, James J. Rusthoven, James Thomas Symanowski et al. · Journal of Clinical Oncology 14 Jul 2003 3,089
2 A Randomized Trial Comparing Lung-Volume–Reduction Surgery with Medical Therapy for Severe Emphysema National Emphysema Treatment Trial Research Group · New England Journal of Medicine Open access 21 May 2003 2,082
3 Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy Moisés Selman, Talmadge E. King, Annie Pardo · Annals of Internal Medicine 16 Jan 2001 1,814
4 Pleural Effusions: The Diagnostic Separation of Transudates and Exudates Richard W. Light, M. ISABELLE MACGREGOR, PETER C. LUCHSINGER et al. · Annals of Internal Medicine Oct 1972 1,794
5 Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010 Andrew MacDuff, A G Arnold, J. Harvey et al. · Thorax Open access Aug 2010 1,502
All 99 most cited papers, with filters and sorting

Where is Pleural and Pulmonary Diseases research done?

The largest centres of Pleural and Pulmonary Diseases research in 2022-now are Tokyo (Japan), Beijing (China), Shanghai (China) and New York (United States).

Largest cities, 2022-now

  1. 1 TokyoJapan 109 works
  2. 2 BeijingChina 102 works
  3. 3 ShanghaiChina 69 works
  4. 4 New YorkUnited States 66 works
  5. 5 LondonUnited Kingdom 62 works
  6. 6 IstanbulTürkiye 58 works
  7. 7 ChengduChina 57 works
  8. 8 SeoulSouth Korea 56 works
  9. 9 New DelhiIndia 53 works
  10. 10 PhiladelphiaUnited States 48 works
See Pleural and Pulmonary Diseases on the map

Where is the best place to study Pleural and Pulmonary Diseases?

Among universities, judged by research, Harvard University, Sichuan University and University of Oxford score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 20.33%fractional works in this field (log) →share of work in the world top 10% →University of OxfordCapital Medical Univ…Harvard UniversitySichuan University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 73.517.9%2.7×47 -23.7%
2Sichuan UniversityChina 72.416.5%3.3×40 +23.8%
3University of OxfordUnited Kingdom 70.224.3%2.7×21 -23.5%
4Capital Medical UniversityChina 67.920.7%5.2×30 +6.7%
5Radboud University NijmegenNetherlands 64.824.8%2.5×8 +121.5%
6Heidelberg UniversityGermany 64.414.8%5.2×22 +14.1%
7Temple UniversityUnited States 61.420.5%6.8×12 +17.0%
8University of Southern DenmarkDenmark 60.719.5%4.8×10 +52.5%
9Tongji UniversityChina 58.824.5%2.4×20 -33.4%
10University of LeicesterUnited Kingdom 58.119.8%6.2×9 +143.6%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Pleural and Pulmonary Diseases, country by country

Is Pleural and Pulmonary Diseases research growing?

Output in 2022-2025 was 0% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Pleural and Pulmonary Diseases.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Pleural and Pulmonary Diseases as a percentage of every work published that year, 0.024% in 2024.

still counting0.020%0.040%0.060%Pleural and Pulmonary Diseases0.026% in 202519801990200020102020

Fractional works of Pleural and Pulmonary Diseases over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Pleural and Pulmonary Diseases10.3% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Pleural and Pulmonary Diseases. Posts are plain text and can be reported.